| HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma H Zheng, W Zhao, C Yan, CC Watson, M Massengill, M Xie, C Massengill, ... Clinical Cancer Research 22 (16), 4119-4132, 2016 | 298 | 2016 |
| Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway W Wang, L Ye, L Ye, B Li, B Gao, Y Zeng, L Kong, X Fang, H Zheng, Z Wu, ... Virus research 128 (1-2), 1-8, 2007 | 283 | 2007 |
| Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response B Li, B Gao, L Ye, X Han, W Wang, L Kong, X Fang, Y Zeng, H Zheng, S Li, ... Virus research 124 (1-2), 44-49, 2007 | 167 | 2007 |
| The membrane protein of SARS‐CoV suppresses NF‐κB activation X Fang, J Gao, H Zheng, B Li, L Kong, Y Zhang, W Wang, Y Zeng, L Ye Journal of medical virology 79 (10), 1431-1439, 2007 | 118 | 2007 |
| Phase I/Ib study of pembrolizumab plus vorinostat in advanced/metastatic non–small cell lung cancer JE Gray, A Saltos, T Tanvetyanon, EB Haura, B Creelan, SJ Antonia, ... Clinical Cancer Research 25 (22), 6623-6632, 2019 | 112 | 2019 |
| Torque teno virus (SANBAN Isolate) ORF2 protein suppresses NF-κB pathways via interaction with IκB kinases H Zheng, L Ye, X Fang, B Li, Y Wang, X Xiang, L Kong, W Wang, Y Zeng, ... Journal of virology 81 (21), 11917-11924, 2007 | 111 | 2007 |
| p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression H Zheng, L Chen, WJ Pledger, J Fang, J Chen Oncogene 33 (6), 734-744, 2014 | 79 | 2014 |
| Regulation of SirT1-nucleomethylin binding by rRNA coordinates ribosome biogenesis with nutrient availability L Yang, T Song, L Chen, N Kabra, H Zheng, J Koomen, E Seto, J Chen Molecular and cellular biology 33 (19), 3835-3848, 2013 | 53 | 2013 |
| The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation Y Zeng, L Ye, S Zhu, H Zheng, P Zhao, W Cai, L Su, Y She, Z Wu Biochemical and biophysical research communications 369 (2), 287-291, 2008 | 44 | 2008 |
| Peptide domain involved in the interaction between membrane protein and nucleocapsid protein of SARS-associated coronavirus X Fang, L Ye, KA Timani, S Li, Y Zen, M Zhao, H Zheng, Z Wu BMB reports 38 (4), 381-385, 2005 | 38 | 2005 |
| Inhibition of HCV RNA-dependent RNA polymerase activity by aqueous extract from Fructus Ligustri Lucidi L Kong, S Li, X Han, Z Xiang, X Fang, B Li, W Wang, H Zhong, J Gao, L Ye Virus research 128 (1-2), 9-17, 2007 | 34 | 2007 |
| Nonlinear dose–response relationship between radon exposure and the risk of lung cancer: evidence from a meta-analysis of published observational studies P Duan, C Quan, C Hu, J Zhang, F Xie, X Hu, Z Yu, B Gao, Z Liu, H Zheng, ... European Journal of Cancer Prevention 24 (4), 267-277, 2015 | 32 | 2015 |
| hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1 H Zheng, L Yang, L Peng, V Izumi, J Koomen, E Seto, J Chen Molecular and cellular biology 33 (24), 4960-4970, 2013 | 31 | 2013 |
| Differential requirement for the IKKβ/NF-κB signaling module in regulating TLR-versus RLR-induced type 1 IFN expression in dendritic cells X Wang, J Wang, H Zheng, M Xie, EL Hopewell, RA Albrecht, S Nogusa, ... The Journal of Immunology 193 (5), 2538-2545, 2014 | 23 | 2014 |
| Expression, purification and characterization of the hepatitis B virus entire envelope large protein in Pichia pastoris X Han, LB Ye, B Li, G Bo, W Cai, Z Hong, YL She, Y Li, LB Kong, ZH Wu Protein expression and purification 49 (2), 168-175, 2006 | 23 | 2006 |
| Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis T Han, S Jiang, H Zheng, Q Yin, M Xie, MR Little, X Yin, M Chen, SJ Song, ... Nature Communications 10 (1), 3716, 2019 | 22 | 2019 |
| Nucleocapsid amino acids 211 to 254, in particular, tetrad glutamines, are essential for the interaction between the nucleocapsid and membrane proteins of SARS-associated … X Fang, LB Ye, Y Zhang, B Li, S Li, L Kong, Y Wang, H Zheng, W Wang, ... Journal of Microbiology 44 (5), 577-580, 2006 | 15 | 2006 |
| Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC). AN Saltos, T Tanvetyanon, BC Creelan, MR Shafique, SJ Antonia, ... Journal of Clinical Oncology 38 (15_suppl), 9567-9567, 2020 | 9 | 2020 |
| MEK inhibition modulates cytokine response to mediate therapeutic efficacy in lung cancer M Xie, H Zheng, R Madan-Lala, W Dai, NT Gimbrone, Z Chen, F Kinose, ... Cancer research 79 (22), 5812-5825, 2019 | 9 | 2019 |
| Combination IFNβ and membrane-stable CD40L maximize tumor dendritic cell activation and lymph node trafficking to elicit systemic T-cell immunity H Zheng, X Yu, ML Ibrahim, D Foresman, M Xie, JO Johnson, TA Boyle, ... Cancer immunology research 11 (4), 466-485, 2023 | 4 | 2023 |
